510(k) · Cleared
ClearedAnthology Hip Stems; CPCS Hip Stems; Femoral Heads; R3 Acetabular Liners; Spectron Hip Stems; Synergy Hip Stems
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Smith & Nephew, Inc. · JDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented
Cleared on Oct 21, 2024 as substantially equivalent to K052792 (Smith & Nephew, Inc., 2005) and 13 other predicates after a 214-day review. Its family tree reaches back 10 generations to 1981.
- Decided
- Oct 21, 2024
- Review
- 214 days
- Class
- Class II
- Product code
- JDI
- Recalls
- None
- Predicates
- 14
Its longest line of descent runs back 10 generations to K810258 (1981). 179 ancestors in all, the oldest K791125 (1979). No later device cites it as a predicate yet.
- Root · 10 generations backK810258 Proximal Fermoral Hip ReplacementBiomet, Inc. · 1981
- 6 generations between
- 3 generations backK082844 Biolox Delta Ceramic Femoral Head, Biolox Delta Ceramic Femoral Head…Encore Medical L.P. · 2008 · Recalled
- 2 generations backK100412 Biolox Delta Ceramic Femoral HeadsSmith & Nephew, Inc. · 2010
- 1 generation backK211176 Smith & Nephew Hip SystemsSmith & Nephew, Inc. · 2022 · Recalled
- This deviceK240783 Anthology Hip Stems; CPCS Hip Stems; Femoral Heads; R3 Acetabular…Smith & Nephew, Inc. · 2024
Show all 10 generations
- Root · 10 generations backK810258 Proximal Fermoral Hip ReplacementBiomet, Inc. · 1981
- 9 generations backK974558 Salvage/Onocology Hip and Total Femur SystemBiomet, Inc. · 1998
- 8 generations backK032396 Ringloc 36MM Line and Modular Femoral HeadsBiomet, Inc. · 2003 · Recalled
- 7 generations backK042051 Arcomxl Polyethylene LinersBiomet, Inc. · 2005 · Recalled
- 6 generations backK051411 Arcomxl Polyethylene Liners and Biolox Delta HeadsBiomet, Inc. · 2005 · Recalled
- 5 generations backK061312 36MM Biolox Delta Ceramic HeadsBiomet, Inc. · 2006
- 4 generations backK071535 Biolox Delta Ceramic Femoral HeadZimmer, Inc. · 2007 · Recalled
- 3 generations backK082844 Biolox Delta Ceramic Femoral Head, Biolox Delta Ceramic Femoral Head…Encore Medical L.P. · 2008 · Recalled
- 2 generations backK100412 Biolox Delta Ceramic Femoral HeadsSmith & Nephew, Inc. · 2010
- 1 generation backK211176 Smith & Nephew Hip SystemsSmith & Nephew, Inc. · 2022 · Recalled
- This deviceK240783 Anthology Hip Stems; CPCS Hip Stems; Femoral Heads; R3 Acetabular…Smith & Nephew, Inc. · 2024
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −10 | K810258 | Proximal Fermoral Hip Replacement | Biomet, Inc. | 1981 | — |
| −9 | K974558 | Salvage/Onocology Hip and Total Femur System | Biomet, Inc. | 1998 | — |
| −8 | K032396 | Ringloc 36MM Line and Modular Femoral Heads | Biomet, Inc. | 2003 | 3 |
| −7 | K042051 | Arcomxl Polyethylene Liners | Biomet, Inc. | 2005 | 1 |
| −6 | K051411 | Arcomxl Polyethylene Liners and Biolox Delta Heads | Biomet, Inc. | 2005 | 1 |
| −5 | K061312 | 36MM Biolox Delta Ceramic Heads | Biomet, Inc. | 2006 | — |
| −4 | K071535 | Biolox Delta Ceramic Femoral Head | Zimmer, Inc. | 2007 | 3 |
| −3 | K082844 | Biolox Delta Ceramic Femoral Head, Biolox Delta Ceramic Femoral Head Offset… | Encore Medical L.P. | 2008 | 1 |
| −2 | K100412 | Biolox Delta Ceramic Femoral Heads | Smith & Nephew, Inc. | 2010 | — |
| −1 | K211176 | Smith & Nephew Hip Systems | Smith & Nephew, Inc. | 2022 | 1 |
| 0 (this device) | K240783 | Anthology Hip Stems; CPCS Hip Stems; Femoral Heads; R3 Acetabular Liners… | Smith & Nephew, Inc. | 2024 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1979 | 1 | 0 |
| 1983 | 4 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 6 | 0 |
| 1993 | 3 | 0 |
| 1994 | 15 | 0 |
| 1995 | 6 | 0 |
| 1996 | 12 | 0 |
| 1997 | 11 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 9 | 0 |
| 2001 | 2 | 0 |
| 2002 | 11 | 0 |
| 2003 | 4 | 0 |
| 2004 | 4 | 0 |
| 2005 | 9 | 0 |
| 2006 | 7 | 0 |
| 2007 | 5 | 0 |
| 2008 | 5 | 0 |
| 2009 | 5 | 0 |
| 2010 | 3 | 0 |
| 2011 | 4 | 0 |
| 2012 | 7 | 0 |
| 2013 | 1 | 0 |
| 2015 | 3 | 0 |
| 2016 | 1 | 0 |
| 2017 | 3 | 0 |
| 2018 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JDI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new JDI device
- #1 K253515 Zimmer Biomet OSS™ Orthopedic Salvage System…score 15.2 · 12 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (14)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K052792 | Anthology Hip StemSummary page 8…r Description Number Date Smith & Nephew, Anthology Hip Stems K052792 10/07/2005 Inc. Smith & Nephew, Global Taper Spectron Hip Stems K970351 02/28/1997 Inc. Smi… | 2005 |
| * | K970351 | Global Taper Spectron Hip StemsSummary page 8…Nephew, Anthology Hip Stems K052792 10/07/2005 Inc. Smith & Nephew, Global Taper Spectron Hip Stems K970351 02/28/1997 Inc. Smith & Nephew, Global Taper Tapered Hip System,… | 1997 |
| * | K963509 | Global Taper Tapered Hip System, GT SpectronSummary page 8…per Spectron Hip Stems K970351 02/28/1997 Inc. Smith & Nephew, Global Taper Tapered Hip System, K963509 01/27/1997 Inc. GT Spectron Smith & Nephew, R3 Multi-Hole Shells and 36mm… | 1997 |
| * | K092386 | R3 Multi-Hole Shells and 36MM Xlpe Acetabular LinersSummary page 8…K963509 01/27/1997 Inc. GT Spectron Smith & Nephew, R3 Multi-Hole Shells and 36mm K092386 11/03/2009 Inc. XLPE Acetabular Liners Smith & Nephew, R3 XLPE Liners… | 2009 |
| * | K113848 | R3 Xlpe LinersSummary page 8…K092386 11/03/2009 Inc. XLPE Acetabular Liners Smith & Nephew, R3 XLPE Liners K113848 04/27/2012 Inc. Smith & Nephew, Reflection 3 Acetabular System K070756 06/06/2007 Inc.… | 2012 |
| * | K070756 | Smith and Nephew Reflection 3 Acetabular SystemSummary page 8…Nephew, R3 XLPE Liners K113848 04/27/2012 Inc. Smith & Nephew, Reflection 3 Acetabular System K070756 06/06/2007 Inc. Porous and Non-Porous Revision Smith & Nephew, Hip Stems of the Revision Hip… | 2007 |
| * | K963486 | Revision Hip SystemSummary page 8…007 Inc. Porous and Non-Porous Revision Smith & Nephew, Hip Stems of the Revision Hip K963486 11/27/1996 Inc System and Heads with Global Taper Smith & Nephew,… | 1996 |
| * | K211176 | Smith & Nephew Hip SystemsSummary page 8…6 11/27/1996 Inc System and Heads with Global Taper Smith & Nephew, Smith & Nephew Hip Systems K211176 07/01/2022 Inc. Smith & Nephew, Smith & Nephew MDF Revision Hip… | 2022 |
| * | K081124 | MDF Revision Hip SystemSummary page 8…Nephew Hip Systems K211176 07/01/2022 Inc. Smith & Nephew, Smith & Nephew MDF Revision Hip K081124 07/31/2008 Inc. System Smith & Nephew, Spectron Extra-Small Straight… | 2008 |
| * | K831884 | Spectron Extra-Small, Straight FemoralSummary page 8…K081124 07/31/2008 Inc. System Smith & Nephew, Spectron Extra-Small Straight K831884 09/20/1983 Inc. Femoral Prosthesis Smith & Nephew, Spectron Long, Straight Femoral… | 1983 |
| * | K823722 | Spectron Long, Straight Femoral ProsthesSummary page 8…4 09/20/1983 Inc. Femoral Prosthesis Smith & Nephew, Spectron Long, Straight Femoral K823722 03/08/1983 Inc. Prosthesis Smith & Nephew, Synergy Cemented Hip Stem K99036… | 1983 |
| * | K990369 | Synergy Cemented Hip StemSummary page 8…K823722 03/08/1983 Inc. Prosthesis Smith & Nephew, Synergy Cemented Hip Stem K990369 03/12/1999 Inc. Smith & Nephew, Synergy Porous Size 8 Hip Stem K991485 07/12/1999 Inc. Smi… | 1999 |
| * | K991485 | Synergy Porous Size 8 Hip StemSummary page 8…Nephew, Synergy Cemented Hip Stem K990369 03/12/1999 Inc. Smith & Nephew, Synergy Porous Size 8 Hip Stem K991485 07/12/1999 Inc. Smith & Nephew, Total Hip Femoral Heads – 12/14… | 1999 |
| * | K021673 | Total Hip Femoral Head - 12/14 TaperSummary page 8…Porous Size 8 Hip Stem K991485 07/12/1999 Inc. Smith & Nephew, Total Hip Femoral Heads – 12/14 K021673 06/11/2002 Inc. Taper Device Description: The purpose of this Traditional 510(k) is the following: 1.… | 2002 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 43 years and passes through 4 companies; a new generation was cleared every 1.5 years on median.
- 44 of the 178 ancestors have a recall of any class.
- 18 other devices also cite its predicate K052792.
How does its category compare?
All JDI devicesJDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.
FDA decisions per year · JDI
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · JDI
59in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · JDI
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JDI
1,644in 2025
MAUDE reports naming product code JDI, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 81 | 26 | 696 |
| 2008 | 5 | 96 | 6 | 810 |
| 2009 | 3 | 65 | 3 | 964 |
| 2010 | 0 | — | 3 | 2,040 |
| 2011 | 2 | — | 5 | 3,160 |
| 2012 | 4 | 167 | 4 | 5,122 |
| 2013 | 3 | 176 | 11 | 5,206 |
| 2014 | 3 | 98 | 3 | 4,968 |
| 2015 | 3 | 190 | 1 | 4,906 |
| 2016 | 4 | 166 | 5 | 3,995 |
| 2017 | 1 | — | 5 | 6,135 |
| 2018 | 1 | — | 1 | 6,728 |
| 2019 | 2 | — | 1 | 7,407 |
| 2020 | 7 | 247 | 77 | 4,015 |
| 2021 | 3 | 162 | 0 | 3,170 |
| 2022 | 3 | 69 | 0 | 1,978 |
| 2023 | 2 | — | 0 | 1,635 |
| 2024 | 3 | 59 | 0 | 1,821 |
| 2025 | 1 | — | 1 | 1,644 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
Hip components are indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant. Hip components are also indicated for…
Read the full statement (503 words)
Hip components are indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.
Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; treatments of nonunion, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, or Girdlestone resection; fracture-dislocation of the hip; and correction of deformity.
Total hip systems may be indicated for use (i) with bone cement, (ii) without bone cement, or (iii) for use with or without bone cement. Refer to the product labeling and literature for specific applications.
Some of the diagnoses listed above may increase risk of complications and reduce the chance of a satisfactory result. Specifically, an increased risk of complications for revision surgery for any reason has been documented in the literature. Patient selection factors such as age, weight, and activity level can negatively affect implant longevity and increase the risk of revision surgery. Literature has shown a high likelihood of revision in younger, heavier, or more active patients. Specifically, the risk of complications is greater in obese and morbidly obese patients.
The Anthology Hip System, CPCS Cemented Hip System, and Synergy Hip System are for primary surgeries only.
The TANDEM Unipolar and Bipolar Hip System is indicated for use in patients not suitable for total hip arthroplasty, with a non-functional femoral head due to femoral neck fracture.
Acetabular Hip Components are indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of degenerative joint disease or any of its composite diagnoses of osteoarthritis, avascular necrosis, and traumatic arthritis.
Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, congenital dysplasia, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques, and fracture-dislocation of the hip.
The Constrained Liners are indicated for primary or revision patients at high risk of hip dislocation due to a history of prior dislocation, bone loss, soft tissue laxity, neuromuscular disease or intraoperative instability and for whom all other options to constrained acetabular components have been considered.
Some of the diagnoses listed above are associated with an increased risk of complications and reduced chance of a satisfactory short- and long-term outcomes. Specifically, an increased risk of complications to revision surgeries for any reason has been documented in the literature. Patient selection factors such as age, weight, and activity level may negatively affect implant longevity and increase the risk of revision surgery. Literature has shown a higher likelihood of revision in younger, heavier and/or more active patients. Specifically, the risk of complications is higher in obese patients.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K240783 · printed Nov 6, 2026
Cite this page
510(k) Report. “K240783: Anthology Hip Stems; CPCS Hip Stems; Femoral Heads; R3 Acetabular Liners; Spectron Hip Stems; Synergy Hip Stems.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K240783
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026